查看購物車
  • Simplified Chinese
  • English
2021-2031年亞太地區第二醫療意見市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843414

2021-2031年亞太地區第二醫療意見市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 118 Pages | 訂單完成後即時交付

價格

亞太地區醫療第二意見市場預計將大幅成長，到 2031 年將達到約 27.2132 億美元，高於 2023 年的 9.0381 億美元，在此期間的年複合成長率(CAGR) 為 14.8%。

執行摘要和市場分析

亞太地區被公認為是醫療二次診療意見成長最快的市場。該市場主要分佈在幾個主要國家，包括中國、日本、印度、韓國、澳洲以及亞太地區的其他地區。值得注意的是，中國、印度和日本是該市場成長的主要貢獻者。主要促進因素包括老齡人口成長、慢性病發病率上升以及政府的支持性措施。此外，遠距醫療和人工智慧 (AI) 在提供二次診療意見方面的日益普及也推動了市場擴張。

市場區隔分析

亞太地區醫療第二意見市場可以根據醫療條件和服務提供者進行細分。

  • 依疾病類型分類：市場分為多種疾病類型，例如癌症、骨科疾病、心臟疾病、神經系統疾病、腎臟疾病、血液系統疾病、慢性阻塞性肺病 (COPD)、器官移植等。 2023 年，癌症領域佔據了市場佔有率的主導地位。
  • 按服務提供者分類：市場也按服務提供者細分，包括醫院、健康保險公司和線上服務。醫院部門在 2023 年佔據了最大的市場。

市場展望

醫療服務與數位平台的融合正在提升數位化諮詢的普及度。這一趨勢使患者無需前往醫療機構即可獲得第二診療意見，從而帶來便利，改善患者體驗並有效管理成本。數位平台支援偏遠地區進行諮詢，從而增加了與醫療專家的聯繫。軟體公司與醫療機構之間的合作正在加速醫療諮詢服務的數位轉型。例如，2021年10月，信諾健康計畫宣布擴展其虛擬護理服務，包括數位優先的初級保健和緊急護理。

國家洞察

亞太地區醫療第二意見市場主要涵蓋中國、日本、印度、澳洲、韓國等國。 2023年，中國佔了最大的市場佔有率。根據世界衛生組織 (WHO) 統計，截至2020年4月，中國報告新增癌症病例約457萬例，癌症死亡病例約300萬例。中國每分鐘都會診斷出一例新的癌症，其中最常見的癌症類型是肺癌、胃癌、乳癌、甲狀腺癌和白血病。

《柳葉刀》雜誌2019年發表的一項研究強調，預計到2040年，中國老齡人口將達到4.02億，老年人更容易患慢性病，因此準確的診斷至關重要。誤診率很高，一項研究表明，中國約72.97%的罕見疾病患者被誤診，凸顯了尋求第二診療意見的重要性。

中國人口眾多，醫療基礎設施先進，加之通訊技術快速發展，使得遠距醫療會診（主要在醫院之間）更加便利。中國的遠距醫療計畫正在提升癌症診療水平，尤其是在農村地區。上海的MediStar Health等公司透過電話會議將患者與外國醫生聯繫起來，而Voycare則開發了一個提供第二醫療意見的線上入口網站，允許患者上傳醫療報告供美國醫療保健專業人員審查。在新冠疫情期間，由於旅行限制阻礙了國際醫療服務的獲取，這項服務顯得尤為重要。

公司簡介

亞太地區醫療第二意見市場的主要參與者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors。這些公司正在採取各種策略，例如市場擴張、產品創新和併購，以增強其產品服務並提高市場佔有率。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：亞太地區第二醫療意見市場格局

  • 概述
  • PEST分析

第5章：亞太地區醫療第二意見市場－主要市場動態

  • 市場促進因素
    • 越來越重視更好的治療效果
    • 醫療成本最佳化的偏好日益增強
  • 市場限制
    • 新興國家對第二醫療意見缺乏認知且不願採納
  • 市場機會
    • 遠距醫療技術合作日益增多
  • 未來趨勢
    • 醫療諮詢服務數位化
  • 促進因素和限制因素的影響：

第6章：醫療第二意見市場－亞太地區分析

  • 2021-2031年亞太地區第二醫療意見市場收入
  • 亞太地區醫療第二意見市場預測分析

第7章：亞太地區第二醫療意見市場分析－依條件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神經系統疾病
  • 腎臟疾病
  • 血液系統疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他

第8章：亞太地區第二醫療意見市場分析－依服務提供者

  • 醫院
  • 健康保險公司
  • 線上服務

第9章：亞太地區第二醫療意見市場－國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第10章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作

第 11 章：公司簡介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 12 章：附錄

Product Code: TIPRE00025235

The Asia Pacific medical second opinion market is projected to grow significantly, reaching approximately US$ 2,721.32 million by 2031, up from US$ 903.81 million in 2023, with a compound annual growth rate (CAGR) of 14.8% during this period.

Executive Summary and Market Analysis

The Asia Pacific region is recognized as the fastest-growing market for medical second opinions. This market is divided into several key countries, including China, Japan, India, South Korea, Australia, and other regions within Asia Pacific. Notably, China, India, and Japan are major contributors to the growth of this market. Key drivers include an increasing elderly population, a rise in chronic diseases, and supportive government initiatives. Furthermore, the growing adoption of telemedicine and artificial intelligence (AI) in providing second opinions is also propelling market expansion.

Market Segmentation Analysis

The Asia Pacific medical second opinion market can be segmented based on medical conditions and service providers.

  • By Condition: The market is categorized into various conditions such as cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. In 2023, the cancer segment dominated the market share.
  • By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. The hospitals segment held the largest market share in 2023.

Market Outlook

The integration of medical services with digital platforms is enhancing the popularity of digital consultations. This trend allows patients to obtain second opinions without needing to visit healthcare facilities, offering convenience, improved patient experiences, and effective cost management. Digital platforms enable consultations from remote areas, increasing access to medical experts. Collaborations between software companies and healthcare institutions are accelerating the digital transformation of medical consulting services. For instance, in October 2021, Cigna Health Plan announced an expansion of its virtual care services, including digital-first primary care and urgent care.

Country Insights

The Asia Pacific medical second opinion market includes key countries such as China, Japan, India, Australia, South Korea, and others. China accounted for the largest market share in 2023. According to the World Health Organization (WHO), there were approximately 4.57 million new cancer cases and 3 million cancer-related deaths reported in China as of April 2020. The country sees a new cancer diagnosis every minute, with lung, stomach, breast, thyroid cancers, and leukemia being the most prevalent types.

A study published in The Lancet in 2019 highlighted that the aging population in China, projected to reach 402 million by 2040, is more susceptible to chronic diseases, making accurate diagnoses critical. Misdiagnosis rates are high, with a study indicating that about 72.97% of patients with rare diseases in China were misdiagnosed, underscoring the importance of seeking second opinions.

China's vast population and advanced healthcare infrastructure, coupled with rapid communication advancements, facilitate telemedicine consultations primarily between hospitals. Telemedicine programs in China are enhancing cancer diagnosis and treatment, particularly in rural areas. Companies like MediStar Health in Shanghai connect patients with foreign doctors via teleconferencing, while Voycare has developed an online portal for medical second opinions, allowing patients to upload medical reports for review by US healthcare professionals. This service became particularly valuable during the COVID-19 pandemic when travel restrictions hindered access to international medical care.

Company Profiles

Key players in the Asia Pacific medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Medical Second Opinion Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Asia Pacific Medical Second Opinion Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Emphasis on Better Treatment Outcomes
    • 5.1.2 Increasing Preference for Healthcare Cost Optimization
  • 5.2 Market Restraints
    • 5.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 5.3 Market Opportunities
    • 5.3.1 Rising Collaborations in Telemedicine Technologies
  • 5.4 Future Trends
    • 5.4.1 Digitalization of Medical Consulting Services
  • 5.5 Impact of Drivers and Restraints:

6. Medical Second Opinion Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Medical Second Opinion Market Forecast Analysis

7. Asia Pacific Medical Second Opinion Market Analysis - by Condition

  • 7.1 Cancer
    • 7.1.1 Overview
    • 7.1.2 Cancer: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Orthopedic Disorders
    • 7.2.1 Overview
    • 7.2.2 Orthopedic Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Cardiac Disorders
    • 7.3.1 Overview
    • 7.3.2 Cardiac Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Neurological Disorders
    • 7.4.1 Overview
    • 7.4.2 Neurological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Nephrological Disorders
    • 7.5.1 Overview
    • 7.5.2 Nephrological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Hematological Blood Disorders
    • 7.6.1 Overview
    • 7.6.2 Hematological Blood Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 COPD
    • 7.7.1 Overview
    • 7.7.2 COPD: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Organ Transplant
    • 7.8.1 Overview
    • 7.8.2 Organ Transplant: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.9 Others
    • 7.9.1 Overview
    • 7.9.2 Others: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Medical Second Opinion Market Analysis - by Service Provider

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Health Insurance Companies
    • 8.2.1 Overview
    • 8.2.2 Health Insurance Companies: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Online Services
    • 8.3.1 Overview
    • 8.3.2 Online Services: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Medical Second Opinion Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.2.2 China: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.3 Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.3.2 Japan: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.4 India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.4.2 India: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.5 Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.5.2 Australia: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.6 South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.6.2 South Korea: Asia Pacific Medical Second Opinion Market Share - by Service Provider
      • 9.1.1.7 Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Medical Second Opinion Market Share - by Condition
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Medical Second Opinion Market Share - by Service Provider

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Market Initiative
  • 10.3 Partnerships and Collaborations

11. Company Profiles

  • 11.1 Second Opinion International
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elite Medical Services
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 The Cigna Group
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Helsana
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 WorldCare
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Vidal Health Insurance TPA Pvt Ltd
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 2nd.MD
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Axa SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Teladoc Health Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Included Health, Inc.
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Royal Doctors
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Medical Second Opinion Market Segmentation
  • Table 2. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 13. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 14. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 15. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 16. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 17. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 18. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Medical Second Opinion Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Asia Pacific Medical Second Opinion Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 6. Asia Pacific Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 7. Cancer: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Orthopedic Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Cardiac Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Neurological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Nephrological Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Hematological Blood Disorders: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. COPD: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Organ Transplant: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Others: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Asia Pacific Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 17. Hospitals: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Health Insurance Companies: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Online Services: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)